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Abstract 
Connexins (Cxs) and pannexins (Panxs) are protein families that form large-pore channels 
which exist at the plasma membrane for both intracellular and extracellular signaling. Given their 
potential for overlapping cellular signaling functions we proposed that mice lacking both a connexin 
and a pannexin would have a severe phenotype. To investigate this possibility we crossed Panx1 null 
mice with Cx40 knockout mice and characterized the first global connexin/pannexin double 
knockout mouse. Intriguingly, the combined ablation of both Cx40 and Panx1 caused decreased 
prenatal and newborn survival, but did not affect the fertility or lifespan of surviving mice. Cx40-/- 
and Cx40-/-Panx1-/- mice had cardiac hypertrophy, and furthermore, combined channel ablation in 
double knockout animals led to increasing severe hypertension and decreased endothelium 
dependent vasodilation. Overall, these studies suggest that even though Panx1 and Cx40 act via 
differential mechanisms, they have a co-regulatory role in certain physiological processes such as 
vascular response. 
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Chapter 1  
1  Introduction 
1.1 Large-pore protein channels in cellular signaling  
Normal cellular function, organ development, homeostasis, and repair after damage relies 
heavily on the initiation of a myriad of critical cellular signaling networks and the interaction of 
extracellular, intercellular, and intracellular cascades1. The connexin (Cx) and pannexin (Panx) 
families of large-pore forming channel proteins facilitate the passage of ions, adenosine 
triphosphate (ATP), and secondary messenger molecules such as calcium, inositol triphosphate 
(IP3) either between cells or in the case of pannexins between a cell and the extracellular milieu2. 
Connexins may act in either intracellular signaling as functional hemichannels, or more often 
form dihexameric gap junction (GJ) channels for direct intercellular communication3. On the 
other hand pannexins exist at the membrane as large-pore channels that function solely in 
extracellular signaling4. It is the interplay between these key cellular signaling modalities that 
allows critical biochemical cascades to occur within systems that rely heavily on gap junction 
and paracrine communication such as the heart and vasculature5.  
1.2 Connexins form gap junctions for direct intercellular 
communication  
Connexins are expressed throughout the body, in many different mammalian cell types. There 
are 21 connexin species in humans (20 in mice) and these polytopic membrane proteins are 
named according to the Cx prefix, followed by their predicted molecular weight in kDa6. Each 
connexin protein has a similar structural topology, and consists of four membrane-spanning 
domains, two extracellular loops (EL), an intracellular loop (IL), and an N-terminus (AT) and C-
terminus (CT)6.  Six Cx subunits oligomerize to form a connexon (Figure 1-1A), which may then 
be transported to the plasma membrane and act as a functional hemichannel in paracrine 
signaling7. Hemichannels are able to pass secondary messenger molecules such as ATP, IP3, 
Ca2+, and NAD+ 7.  However, more often a connexon docks with its counterpart on an opposing 
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cell to form a gap junction (GJ) channel8. Gap junctions allow for intercellular communication 
via the joining of cytosolic compartments between adjacent cells8. Areas of high membrane 
apposition that contain a large number of GJ channels are termed GJ plaques9. GJ plaques allow 
for a diverse range of intercellular signaling events including the passage of ions, electrical 
signal, and secondary messenger molecules less than 1000 Da9.  
Connexons can be homomeric or heterotypic depending on if they are composed of the same Cx 
isoform or are mixed10. Furthermore GJ channels are defined as homotypic if they are comprised 
of the same connexon subtype, or heterotypic if they are composed of two different homomeric  
or heteromeric connexons (Figure 1-1B)10. Each connexin channel has different GJ intercellular 
communication capabilities regulated by variations in pore size, conductance, open channel 
probability, pH gating, and charge selectivity11.  
In the human population just under half of the connexin family members (10 Cx subtypes) have 
been linked to genetically inherited diseases12. These diseases range from mild to severe, and 
include skin abnormalities, deafness, oculodentodigital dysplasia, hypertension and cardiac 
arrhythmias12.  This thesis will focus on Cx40, a connexin family member linked to hypertension 
and cardiac arrhythmias13, and its roles within the cardiovascular system.   
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Figure 1-1. Connexins are subunit proteins that form GJs for intercellular communication 
(A) A typical GJ protein contains 4 membrane spanning domains, two ELs, an IL, and an AT and 
CT. Six Cxs oligomerize to form a connexon. (B) Two connexons from apposing cells may dock 
to form GJs which may be homotypic, heterotypic, or mixed. Reused with permission: Laird 
DW. Life cycle of connexins in health and disease. The Biochemical Journal 2006;394:527–543. 
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1.3 Pannexins form large-pore channels for extracellular 
communication  
The pannexin family has three isoforms: Panx1, Panx2, and Panx3. Panx1 expression is 
ubiquitous, and it is found in many organs including the brain, heart, skin, spleen, lungs, blood 
vessels, and kidney14, 17. Panx2 has a more restricted expression, being localized to the central 
nervous system, particularly in brain structures such as the hippocampus and olfactory bulbs14. 
Finally, Panx3 has been discovered in varying levels in the arteriole networks, skin, cartilage, 
liver, lung, thymus, and spleen14. All three pannexin isoforms demonstrate similar predicted 
structural topology, but no sequence homology to their connexin cousins15. Panxs have four 
membrane-spanning domains, two EL’s, one IL, and AT- and CT15. Panx1 and Panx3 are more 
structurally homologous, whereas Panx2 exhibits a longer C-terminus15. Similarly to connexins, 
pannexins oligomerize to form pannexons that undergo initial posttranslational modifications in 
the endoplasmic reticulum (N-glycosylation) before they are transported through the Golgi 
apparatus to the plasma membrane. There they may act as large-pore channels to facilitate 
extracellular signaling of small nucleotides and secondary messengers such as ATP and Ca2+16. 
Interestingly, unlike connexins, pannexin 1 has a long half-life of up to 32 hours17. Panx1 is 
known to play a role in several human pathologies including cancer18 and hearing loss19. 
Unfortunately its role as a large-pore channel in the cardiovascular system, and its potential 
interactions with GJs in cellular signaling cascades within these systems has yet to be fully 
explored.    
1.4 Connexin hemichannels in paracrine signaling  
Since the discovery of pannexins the idea of connexin hemichannels, or connexons, remaining 
undocked at the plasma membrane to participate in paracrine cellular signaling events, and 
particularly in the release of ATP, has been a subject of debate12. Under standard physiological 
conditions connexin hemichannels are usually found in a closed conformation20. However these 
hemichannels have been induced to open experimentally, and act in the release of ATP as a 
secondary messenger. A caveat to these findings is that many experiments relied on artificial 
cellular environments to achieve their results21. For example, in most cases the release of ATP 
was only achieved through overexpression of connexin molecules in unpaired cells at a very low 
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extracellular Ca2+ concentrations, an environment which enhanced channel open probability21. In 
contrast, a few connexin subtypes, namely Cx26, Cx43, Cx46, and Cx50 have been found to 
form functional hemichannels under normal physiological conditions, although the extent to 
which they participate in extracellular signaling remains unclear22-24.  
Interestingly, both connexin hemichannels and pannexin channels have been reported to open 
under cellular stress conditions including ischemia, hypotonic stress, low oxygen tension, and 
mechanical stimulation (topic extensively reviewed by Lohman and Isakson)21. Hemichannels 
under pathological conditions experiencing uncontrolled opening are often referred to as leaky 
hemichannels25. Moreover, along with cellular stress responses, mutations in human connexin 
genes have also been linked to the formation of leaky hemichannels, and subsequent cell death25. 
An example of this phenomenon was demonstrated when researchers overexpressed human 
Cx40 gene mutants associated with idiopathic atrial fibrillation in N2A cells and found that one 
mutation (G38D) led to a gain-of-function in forming leaky hemichannels26. Unfortunately, Cx40 
hemichannels have yet to be identified in native cell systems.  
1.5 An overview of inter/intracellular communication in 
cardiovascular physiology  
The heart is composed of two main functional components: the conduction system, and the 
working myocardium27. It is the junctions within the heart, and in particular GJs, that allow for 
the spread of electrical activity from the conduction system to the working myocardium and 
consequently the synchronized contraction of the cardiac tissue28. Without coordinated 
contraction the heart is at risk for atrial and ventricular arrhythmias, which could ultimately lead 
to ischemic events and heart failure27. Furthermore, the regulation of paracrine signaling within 
the heart in normal physiology and under pathological conditions is of key importance because 
aberrant signaling may lead to triggered propagated contractions and arrhythmogenic 
phenotypes58. To date members of connexin and pannexin gene families have been implicated in 
cardiac physiology due to their roles in GJ intercellular communication and purinergic 
signaling29.    
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Another important part of the cardiovascular system in which both connexins and pannexins 
have been shown to participate in integral physiological processes is the vasculature30, 31. Arteries 
regulate blood flow and may be divided into distinct subcategories based on their size and 
function32. Conducting arteries, such as the aorta, are the largest vessels within the body, and are 
elastic in nature32. Conduit arteries are medium sized arteries that stem from conducting arteries 
and branch into resistance arteries to allow for the perfusion of organ systems and maintenance 
of adequate blood pressure. Resistance arteries, like the thoracodoral artery (TA) are muscular in 
nature33. Depending on their size arteries are composed of varying levels of smooth muscle and 
endothelial cells, and consequently display differential connexin/pannexin expression 
profiles34.35. Notwithstanding, both smooth muscle and endothelial cell layers within arteries 
require both intracellular and extracellular signaling for the spread of secondary messenger 
molecules, current, depolarization and hyperpolarization waves for vasoconstriction and 
vasodilation36. Intriguingly, both Cx40 and Panx1 channels have been found to play pivotal roles 
in the regulation of these processes37, 38 as will be explored in detail in subsequent sections. 
Finally, large-pore channels within the renal system contribute significantly towards 
cardiovascular homeostasis and the regulation of blood pressure39. In fact, connexins are highly 
involved in two central feed-back mechanisms instrumental to the control of arterial pressure40. 
Surprisingly, through its role as a large-pore ATP release channel, Panx1 has recently been 
implicated in these vital physiological processes as well41.  
1.5.1 The role of cardiac connexins in normal and diseased physiology   
The conduction system of the heart relies heavily on GJ intercellular communication for the 
spread of action potentials (AP) from one cardiomyocyte to the next beginning with the 
pacemaker cells in the sinoatrial node and propagating to the cristae terminalis and atrial tissue42. 
Next the AP travels through the atrioventricular (AV) node, atrioventricular bundle, bundle 
branches, purkinje fibers, and finally the ventricles42. Without the myocardium functioning as a 
synchronous unit the heart cannot pump blood throughout the body in an efficient manner and is 
prone to fibrillations and irregular rhythm43.  
Connexin family members that play a role in GJ communication in the heart are Cx43, Cx45, and 
Cx40, which are found throughout the heart and at the intercalated discs of cardiomyocytes43. 
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The presence of three different connexin family members within the heart allows for an 
increasingly diverse GJ composition and thus regulation of the speed and direction of impulse 
propagation43. Cx43 is the most abundant isoform present in cardiac tissue and is located at the 
junctions between cardiomyocytes in the working myocardium of the atria and ventricles44. 
Interestingly, although the ablation of this connexin in mice is neonatally lethal, it has been 
found that cardiomyocyte-specific ablation of Cx43 does not lead to alterations in heart 
morphology, however mice die spontaneously due to ventricular arrhythmias45. In addition, mice 
heterozygous for the Cx43 gene display no changes in cardiac conduction46.   Cx45 is essential 
for early embryonic myocardial development and its ablation in global and cardiac specific 
knockout mouse models causes embryonic lethality47. Interestingly, using a tamoxifen-inducible, 
cardiac specific, knockout mouse model it was shown that Cx45 is non-essential in the heart of 
older mice, as gene ablation produced only minor alterations in AV nodal propagation47. Finally, 
Cx40 is localized to the working myocardium in the atria and cardiomyocytes of the conduction 
system of the heart (Figure 1-2)44.  
The role of Cx40 within the heart is quite diverse as it is the only cardiac connexin expressed in 
both the working myocardium and the conduction system. Cx40 knockout mice are viable 
making them an amenable model to study the function of GJs within the cardiac system48. Not 
only does Cx40 function in the propagation of action potentials, slow wave calcium (Ca2+) 
signaling, and synchronous beating of atrial cardiomyocytes48, but it also plays a role in cardiac 
development. Previous studies performed on wild type mice show that both the Cx40 transcript 
and protein are dynamically regulated within the heart during development49. At embryonic day 
(E) 11 Cx40 is widely distributed throughout the atria and ventricle primordia in the unorganized 
embryonic conduction system49. However by E14 the ventricular conduction system begins to 
differentiate and Cx40 recedes from the ventricular trabecular network to take on a more 
restricted distribution in the proximal segment ventricular conduction system, namely the His-
bundle and the upper parts of the bundle branches, and throughout the atria49. Intriguingly, Cx40 
is also involved in the structural development of the heart. Assessment of the morphology of 
young and adult Cx40-/- mouse hearts revealed that this mutant possessed several structural 
anomalies including septation defects, and cardiac hypertrophy50. Cx40 also plays a crucial role 
in the propagation of action potentials within the cardiac conduction system, and throughout the 
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atria51. Functional studies performed on Cx40 knockout mice revealed that the absence of this 
protein caused decreased automaticity, slower AP propagation throughout the atria and AV-
node, and finally upper bundle branch block associated with first degree AV block51.   
Much like the mouse, in the human population Cx40 also plays a role in cardiac health52. Patients 
with idiopathic paroxysmal or chronic atrial fibrillation (AF) display up to a 77% reduction of 
Cx40 protein in atrial tissue compared to tissues obtained from a non-diseased heart52. As well, it 
has been found that a few idiopathic AF patients display either somatic and germline mutations 
in GJA5, the gene encoding Cx40. So far, 6 germline mutations, and 3 somatic mutations in the 
GJA5 gene have been identified in a total of 23 patients53. Functional studies on several of these 
mutations revealed compromised Cx40 GJ and hemichannel function, pointing towards the 
importance of this connexin family member in heart health53. All in all, the ablation of Cx40 in a 
transgenic mouse model seems to be the most attractive method to study the role of GJs in 
cardiovascular physiology, not only because these mice are viable and still display an irregular 
cardiac phenotype, but also because the knockout of this gene may result in similar pathologies 
to those seen in loss of function GJA5 gene mutations within the human population.  
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Figure 1-2. Localization of connexins within the heart 
Cx40, Cx43, and Cx45, can be found throughout the heart, in both the working myocardium of 
the atria and ventricles and the cardiac conduction system. Reused with permission: Severs NJ, 
Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in 
diseased myocardium. Cardiovascular research 2008;80:9–19. 
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1.5.2 Panx1, slow wave Ca2+ propagation, and atrial arrhythmias 
Panx1 is the most prevalent pannexin family member expressed in the cardiovascular system, 
and the only Panx localized to the heart54. Panx1 mRNA is present throughout the heart, in both 
the atria and ventricle with slightly higher transcript levels being localized to the atria54. It has 
also been identified in various cardiovascular cell types including cardiomyocytes, endothelial 
cells, and smooth muscle cells55. Its function within the cardiac system remains somewhat 
unclear, however, it is known that Panx1 acts as a major ATP release channel in cardiomyocytes 
following injury or inflammation56.  As well, it has been hypothesized by several groups that 
Panx1 may contribute to inter- and intracellular slow wave calcium signaling via purinergic 
signaling and subsequent Ca2+ release from intracellular stores that then diffuses from cell to cell 
via GJs57 (Figure 1-3). Slow wave calcium signaling within the heart typically occurs at a rate of 
0.1 mm/s, and can lead to a depolarization wave and triggered propagating contractions 
(TPCS)58. TPCs may lead to an arrhythmogenic phenotype58. Remarkably, Panx1-/- mice also 
exhibit increased susceptibility to atrial fibrillation, a prolonged QT wave phenotype, and a 
higher incidence of AV block54. Although Cx40 GJ channels and Panx1 single membrane 
channels play different roles in cardiac physiology as previously outlined, they are both localized 
similarly, in the atria, participate in similar signaling cascades such as slow wave calcium 
signaling, and their ablation within knockout mouse models leads to a similar arrhythmogenic 
cardiac pathology.  
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Figure 1-3. Cx40 and Panx1 large-pore channel calcium wave propagation 
Proposed mechanism concerning the participation of Cx40 and Panx1 large-pore channels in 
paracrine and GJ signaling interactions involving the passage of ATP and secondary messenger 
molecules IP3 and Ca2+ in order to cause intracellular calcium store release and contribute to slow 
wave calcium propagation in some cell types. Modified with permissions from: D’hondt C, 
Ponsaerts R, Smedt H De, Bultynck G, Himpens B. Pannexins, distant relatives of the connexin 
family with specific cellular functions? BioEssays 2009;31:953–974. 
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1.5.3 Connexins in vascular physiology  
The regulation of vascular tone and coordination of vasomotor response is essential for the 
control of blood pressure in normal physiology. Often, these responses are regulated by the 
passage of ions and secondary messengers between coupled vascular cells59. Endothelial-
endothelial, smooth muscle-smooth muscle, and myoendothelial cell coupling is accomplished 
by Cx37, Cx40, Cx45, and Cx4360. More specifically, Cx40 allows for coupling between 
endothelial cells and the spreading of vasodilatory signals, Cx43 and Cx45 for the coupling of 
smooth muscle cells, and finally Cx37, Cx40, and Cx43 for the formation of myoendothelial 
junctions60. In large arteries, such as the aorta or coronaries, Cx37 and Cx40 are the most 
abundant connexin subtypes in the endothelium, and Cx43 the most abundant in smooth 
muscle61. Contrastingly, in small resistance arteries Cx40 and Cx45 are more abundant in the 
smooth muscle cells than Cx4361. Certain pathologies such as hypertension may cause alterations 
in the connexin expression profile in a tissue specific fashion, and this effect has been 
demonstrated both within the blood vessels and within the kidneys62. For example in mouse and 
rat models in which renal hypertension is experimentally induced it has been found that Cx43 
and Cx40 transcript and protein levels are increased in the kidneys62. In contrast, when 
hypertension is induced by inhibiting endothelial nitric oxide synthase, an enzyme associated 
with the production of nitric oxide in the vasculature, Cx37 and Cx43 levels are reduced within 
the vessels and Cx40 remains unaffected62.   
Unfortunately Cx37 null mice mainly exhibit phenotypes that are non-vessel related63. 
Contrastingly, Cx45 knockout mice exhibit a severe vascular phenotype and embryonic lethality 
(E9.5-E10.5) characterized by abnormally enlarged or narrowed vessels, diminished yolk sack 
vessel formation, and hindered smooth muscle cell differentiation around large arteries63. 
Endothelial cell specific knockouts of Cx43 have demonstrated that this connexin protein may be 
important in vasodilation as select knockout models exhibit hypotension that was hypothesized 
to be due to increased nitric oxide (NO) production64.  Finally, transgenic mice in which the 
Cx40 gene has been ablated show impairments in vasomotor responses including altered 
contraction and relaxation profiles65. Mice lacking Cx40 display blunted conducted vasodilation 
responses in both arterioles and larger arteries in response to endothelium dependent vasodilators 
like acetylcholine65. Interestingly, receptor dependent vasocontractile responses to phenylephrine 
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agonists are enhanced in some Cx40-/- mouse stuides66. This was hypothesized to be due to 
endothelial dysfunction leading to a lack of coordinated contraction/relaxation balance within the 
vessels in question66.  
1.5.4 The functional role of Panx1 within large and small arteries  
Although there are three Panx family members, Panx1 is the primary species expressed in the 
vasculature67. Panx1 has been localized to both endothelial cells and smooth muscle cells68. 
Intriguingly, the distribution of Panx1 in smooth muscle cells is graded, and vessels greater than 
300 μm in diameter do not express Panx1 in smooth muscle67. Therefore, in large arteries like the 
aorta, Panx1 is predominately localized to the endothelium. As well, interestingly, it has been 
reported that global Panx1 knockout mice show compensatory upregulation of Panx3 channels in 
the thoracodorsal artery (TDA)68.  
In the vasculature Panx1 has been implicated in altered vasomotor responses in conduit arteries 
by regulating endothelium derived hyperpolarizing factor (EDHF)38 and in small resistance 
arteries by modulating vasoconstriction68. The ability of the Panx1 channel to regulate vasomotor 
responses is speculated to be due to their ability to act as an ATP release channel in order to 
modulate slow wave Ca2+ signaling under differential physiological conditions55, 56, 69. For 
example in conduit arteries Panx1 participates in the relaxation response by mitigating EDHF 
responses. In fact, global Panx1-/- mice display increased resistance due to the blunted response 
of arterioles to muscarinic receptor agonist acetylcholine38. Meanwhile in small resistance 
arteries like the TDA it has been found that Panx1 shares a functional link with α1D-adrenergic 
receptors (α1D-AR)70. When norepinephrine is released from sympathetic nerves to activate 
α1D-ARs there must be concomitant activation of purinergic receptors or the contractile 
response of the artery is blunted70. Furthermore, it was found that Panx1 played a role in 
purinergic receptor activation because when phenylephrine, a α1D-AR agonist was applied to the 
TDA after Panx1 channel inhibition vasoconstriction was blunted70.  
Contrastingly, in two separate studies it has been found that a) Panx1 does not mediate α1D-AR 
vasoconstriction in resistance arteries, and b) that ATP is not required for α1D-AR-mediated 
constriction71, 72. Their protocols utilized both TDA and mesenteric small resistance arteries, and 
a variety of Panx1 inhibitors71, 72. Therefore due to the controversy in this field concerning the 
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roles of Panx1 in small resistance arteries, and the exhaustive amount of research that has already 
been performed on the contributions of Panx1 to vasoconstriction in the TDA, we propose 
instead to assess the role of Panx1 in endothelial cell function. As mentioned, endothelium 
integrity was previously measured in conduit arteries of Panx1-/- mice and found to be 
dysregulated. We therefore postulate that in an increasingly large artery, such as the aorta, which 
contains higher levels of endothelial Panx1, the severity of the phenotype would be increased.  
Much like in the atria of heart, the roles of Panx1 and Cx40 in large arteries and consequently, 
the aorta seem to overlap. Within larger arteries both of these key large-pore channels are 
localized to the endothelium61, 67, play a role in vasodilation albeit via differential mechanisms, 
and their ablation leads to endothelial dysfunction38, 65, 66. It is therefore worth considering what 
the effect of the combined ablation of Cx40/Panx1 large-pore channel proteins would have not 
only on the heart, but also within the vasculature.  
1.5.5 Connexins and pannexins in the renal system  
The kidneys play a pivotal role in modulating cardiovascular system response by regulating 
blood pressure and peripheral resistance through two central processes: pressure natriuresis 
regulation and by releasing neurohormonal vasoactive factors73. Interestingly, both of these 
processes are in part modulated by connexins76. Pressure natriuresis is a feedback mechanism in 
the renal system used to control blood pressure by closely regulating sodium and water balance74. 
In short, rises in arterial pressure lead to increased perfusion pressure within the renal artery. 
This then causes increased sodium and water excretion, and decrease in the level of extracellular 
fluids ultimately resulting in decreased blood pressure73. Pressure natriuresis is a regulatory 
mechanism that occurs irrespective of the stimulus that provoked the initial increase in arterial 
pressure73.  
The renin-angiotensin-aldosterone system (RAAS) in the kidney works alongside the pressure 
natriuresis mechanism to maintain a normalized blood pressure by releasing neurohormonal 
factors74. Increases in arterial pressure lead to the inhibition of the RAAS system, a reduction of 
angiotensin II production, reduced vasoconstriction on the afferent arterioles of the kidney, and 
finally decreased sodium reabsorption74. Contrastingly, the activation of RAAS through the 
secretion of renin from the kidneys provokes angiotensin converting enzyme to convert 
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angiotensin I into angiotensin II which then acts to cause increased vessel constriction, increases 
in blood pressure, and ultimately hypertension through increased fluid reabsorption75.  
Connexins have been localized to the cortex and medulla of the kidney, and throughout the renal 
vasculature76. Importantly, within the nephron Cx43, Cx40, Cx30, Cx37, and Cx45 are found77. 
Physiologically within the kidney connexins participate in several regulatory mechanisms 
including the RAAS, in tubuloglomerular feedback and pressure natriuresis76. More specifically 
Cx40 is found within the endothelial cells of the juxtaglomerular apparatus, and other parts of the 
renal microcirculation78. As a prominent member of the kidney microcirculation Cx40 may act as 
a mediator of slow wave Ca2+ signaling in order to modulate vascular conductance and 
endothelium mediated vasodilation of the arteries in order to control glomerular filtration rates77. 
Studies have also shown that Cx40 plays an important role in renin synthesis and release, 
contributing to autoregulation mechanisms (RAAS feed-back) within the kindey78, 79.  
In addition, Panx1 and Panx3 channels have been localized within the kidney. Panx1 is present 
in both cortical and medullary tubule segments of the kidney and in the renal vasculature80, while 
Panx3 has a more restricted distribution pattern and is found only within the renal vasculature77. 
Unfortunately little is known about the role of Panx1 in the renal system. However based on its 
similar localization profile to Cx30 within the apical collecting ducts, and its role in purinergic 
signaling, it has been hypothesized that Panx1 may play a role in pressure natriuresis80. It has 
also been postulated that Panx1-/- mice might possess a salt retention phenotype that would 
consequently lead to hypertension80. 
1.6 Signaling in receptor-dependent and independent vasomotor 
responses   
Vascular tone is an important part of system homeostasis and is maintained by local 
vasoconstriction and dilatory responses81. In general vasoconstriction may be either receptor-
dependent or independent and is regulated by smooth muscle cell contraction82. Contrastingly, 
vasodilation is mediated by the endothelium which releases a variety of vasoreactive factors in 
the regulation of smooth muscle relaxation such as nitric oxide (NO) and endothelium-derived 
hyperpolarizing factor (EDHF)81. The assessment of the vasoreactivity of a vessel to various 
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agonists causing constriction/relaxation is often used as a measure of endothelial function83, and 
therefore this approach will be utilized in this thesis to study the effects of the ablation of 
Panx1/Cx40 in the aorta. Because these methodologies will be employed, key signaling 
pathways involved in these responses are delineated.  
α-adrenergic receptor mediated contraction is one of the central pathways that mediate 
vasoconstriction, and one that has been utilized in this thesis to examine the contractile responses 
of the aorta. Adrenergic receptors are G-protein coupled receptors (GPCR) that are activated by 
catecholamine agonists84. They are found within the in the cardiovascular system and have been 
divided into two main subtypes: α-adrenergic receptors (α-ARs) and β-adrenergic receptors84. In 
the vasculature α-ARs are surface receptors located on smooth muscle cells that play a role in 
vasoconstriction85. α1-ARs are activated by the release of neurotransmitters from the 
sympathetic nervous system or by drug agonists such as phenylephrine (PE) and methoxamine85. 
The GPCR then initiates an intracellular cascade by activating the membrane bound 
phospholipase C protein (PLC). Once activated PLC stimulates the production of IP3 and 
diacylglycerol, two secondary messengers which act on intracellular Ca2+ stores and cause their 
release. The rise in intracellular Ca2+ ultimately leads to vasoconstriction of the artery84, 85.  
Similarly potassium (K+) channels are important for the regulation of smooth muscle cell 
membrane potential and excitability. In brief the phenomenon of K+ mediated vasodilation and 
vasoconstriction will be explained86. The opening of these channels leads to K+ efflux, 
hyperpolarization of the membrane, closure of voltage gated Ca2+ channels, and ultimately 
smooth muscle cell relaxation86. In contrast, the closing of these channels causes membrane 
depolarization, opening of voltage gated Ca2+ channels, and ultimately vasoconstriction87. In total 
there are four different types of K+ channels including: calcium activated-K+ channels, voltage 
dependent K+ channels, ATP-sensitive K+ channels, and inwardly rectifying K+ channels87.  
Nitric oxide is a potent vasodilator and acts through activation of intracellular cascades which 
ultimately cause shifts in actin/myosin chain dynamics, muscle relaxation, and thus 
vasodilation88. In endothelial cells nitric oxide is synthesized from amino acid L-arginine by 
endothelial nitric oxide synthase88.  NO can then diffuse from endothelial cells into SMCs and 
activate membrane bound receptor soluble guanylyl-cyclase (sGC)89. Activated sGC produces 
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secondary messenger cyclic guanylyl monophosphate, which induces protein kinase G (PKG). 
PKG, causes the reuptake of cytosolic Ca2+, promotes the opening of Ca2+ dependent K+ 
channels, and activates myosin light chain phosphatases89. These factors cause the 
dephosphorylation of the myosin light chain, and the hyperpolarization of SMCs, which inhibits 
muscle contraction and subsequently leads to vasodilation88, 89.   
Sodium nitroprusside is a NO donor, often used to study nitric oxide mediated vasodilation in an 
endothelium independent manner90. SNP acts by breaking down into its molecular components 
and releasing nitric oxide into the blood stream90. Nitric oxide can then act directly on SMCs to 
induce a vasodilatory response91. The use of SNP along with other endothelial dependent 
vasodilators such as methacholine allows researchers to assess endothelium function91.  
Muscarinic (M3) receptor mediated vasodilation is a pathway that causes smooth muscle cell 
relaxation in the vasculature92. M3 receptors are GPCRs located on the endothelium that may be 
stimulated by various non-selective agonists such as methacholine and acetylcholine92. Once 
activated these GPCRs act to initiate PLC and IP3 secondary messenger signaling cascades that 
lead to rises in intracellular Ca2+, and the formation of NO93. Nitric oxide may then diffuse from 
the endothelium to SMCs in order to exert a vasodilatory effect as previously mentioned. 
Intriguingly, this pathway is often used to assess endothelial function, as the NO mediated 
vasodilatory function of the endothelium is often deregulated upon damage92. 
Ca2+ is required for the contraction of smooth muscle cells, where the extent of contraction is 
dependent on the intracellular levels of this ion. Intracellular rises in Ca2+ cause decreases in 
membrane polarization and activation of voltage-gated calcium channels and influxes of this 
molecule into the cell94. Interestingly, voltage-gated calcium channels are expressed in a graded 
manner the vasculature, wherein channel number increases as vessel size decreases93. Although 
calcium is vital to vasoconstriction, it is not thought that this secondary messenger itself could 
cause synchronized contraction over long distances, rather that it acts through GJs as a 
messenger molecule along the length of vessel or from cell to cell to amplify or maintain the 
contractile response93.  
Calcium also plays an important role in endothelium mediated vessel relaxation. Endothelial 
cells lining the lumen have a variety of surface receptors that are stimulated upon interaction 
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with ATP, circulating hormones or by changes in blood flow95. Many of these receptors such as 
metabotrophic P2Y receptors, are G-protein coupled receptors, which will then initiate 
intracellular cascades to cause rises in IP3 and subsequently Ca2+ concentration95. Rises in 
endothelial cell Ca2+ will activate ion channels and promote synthesis of secondary messenger 
molecules, such as prostacyclin, nitric oxide (NO), and endothelium derived hyperpolarizing 
factor96. These signaling molecules are termed endothelium derived relaxing factors, and 
ultimately cause the relaxation of the smooth muscle cell layer of the vessel96.  
1.7 The role of Cx40 and Panx1 in blood pressure regulation  
Previous studies have shown that the ablation of the Cx40 gene in the mouse creates a 
hypertensive phenotype37, 79. Research has found that this increase in systolic/diastolic pressure is 
not a consequence of Cx40 channel loss from the vasculature97. This was determined when Cx40 
was selectively deleted from the endothelium and transgenic mice remained normotensive 
despite blunted arteriole relaxation97, 98. Remarkably, it was found that the hypertensive 
phenotype in the global Cx40 knockout mouse was not salt sensitive but rather due to alterations 
in the renin-angiotensin-aldosterone system (RAAS)99. More specifically, the ablation of Cx40 
impairs the negative feedback loop of pressure on renin release, resulting in excess renin 
excretion99. To elaborate on these findings, hypertensive Cx40-/- mice were rendered 
normotensive when the RAAS was inhibited via ACE or angiotensin II receptor blockers100. 
When this hypertension was further explored it was found that selective ablation of Cx40 from 
the renin producing cells of the kidney created the same phenotype found in the global Cx40 
knockout mice100. Furthermore Cx40-/- mice have increased plasma renin and aldosterone 
concentrations100, 79.  
In humans, single nucleotide polymorphisms in both the intron and promotor region of the Cx40 
gene (GJA5) have been associated not only with idiopathic atrial fibrillation but also 
hypertension and left ventricular hypertrophy in males101, 102. More specifically, polymorphisms 
were located in the promoter region of the minor Cx40 allele at position S44AA/R71GG and 
within the intron at RS791295101, 102.  
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Previous reports have demonstrated a role for Panx1 in blood pressure regulation and peripheral 
resistance through various mechanisms. One involves Panx1 channels on erythrocytes being 
activated to release ATP in conditions where there is low blood pO269. This nucleotide would 
then induce vasodilation in the artery in question69.  Similarly, the carotid body, known for its 
role in maintaining blood pO2 balance, possesses Panx1 channels, and has been shown to act as 
an ATP amplifier by releasing of ATP onto receptor type II cells which then propagates this 
release onto afferent nerve terminals103. Afferent nerve terminals would ultimately relay this 
signal to cardiorespiratory centers in the medulla oblongata for the regulation of blood pressure 
and respiratory rate103. Therefore, it has been shown that Panx1 plays a significant role in 
hypoxia-induced vasodilation69, 103.  
In addition, a previous mouse study shows that when Panx1 is specifically ablated from smooth 
muscle cells, those partial knockout animals are slightly hypotensive104. This effect was 
hypothesized to be due to the role that Panx1 channels play in mediating α-1D-adrenergic 
receptor signaling in vasocontraction in small resistance arteries104. As well, as previously 
delineated Panx1 may play a role in pressure natriuresis80 and Panx1-/-mice might possess a salt 
retention phenotype and consequently hypertension80. 
Therefore not only have Cx40 and Panx1 channels been implicated in similar localization 
profiles within the atria44, 54 and aorta31, 67, and similar functions within the heart and vessels, but 
they are also both linked to blood pressure regulation80, 100, 104. As this is a widespread 
physiological process that occurs via the interaction of multiple organ systems and mechanisms 
within the body it would be interesting to observe the effect of the combined ablation of these 
two large-pore channel proteins on blood pressure regulation.  
1.8 Hypertension and its associated risk factors  
Arterial pressure depends on two main variables: peripheral resistance and cardiac output105. 
Peripheral resistance is mediated by small arteries, whereas cardiac output is influenced by blood 
volume, and is thus under renal control105. Hypertension is defined as abnormally high blood 
pressure, and is a rising epidemic that affects more than 25% of the global population and is one 
of the leading causes of mortality in developed countries106. Hypertensive vessels are 
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characterized by increased medial and reduced luminal area, along with increased ECM 
proteins107. This disease if often asymptomatic until later in life and is associated with several 
risk factors such as cardiac hypertrophy, myocardial infarction, aortic dissection, endothelial 
dysfunction, atherosclerosis, stroke, and chronic kidney disease108. In relation to the role that 
hypertension plays in the development of myocardial hypertrophy, endothelium dysfunction will 
be delineated as well as the roles that both connexin and pannexin large-pore channels play in the 
development of this multifactorial disease109. 
1.8.1 Cardiac hypertrophy induced by pressure overload  
Cardiac hypertrophy is an adaptive response, and a pathophysiological condition that arises due 
to increased volume/pressure load, sarcomeric mutations or dysfunction, and decreased myocyte 
contractility after tissue injury110. Hypertrophic growth induced by increased pressure/volume 
load is secondary to several pathologies including hypertension, ischemia, valvular disease, and 
heart failure110. Pressure overload hypertrophy is a topic that is central to this thesis project and 
will therefore be discussed in detail.  
Arterial hypertension is the most common cause of pressure overload within the heart and may 
lead to pronounced left ventricular hypertrophy (LVH)111. Pressure induced hypertrophy is 
believed to occur as a physiological compensation mechanism that the myocardium undergoes in 
order to decrease left ventricular wall stress and oxygen consumption111. The left ventricle is 
often the most affected cardiac region as it has the greatest workload111. At the molecular level 
muscle wall thickening is due to biomechanical stress potentiating changes in cardiac gene 
expression, the reactivation of the fetal gene program (α-myosin heavy chain, atrial natriuretic 
peptide, and brain natriuretic), and ultimately the growth of the cardiomyocytes112. Along with 
increases in cardiomyocyte area cardiac hypertrophy is often accompanied by augmented 
interstitial myocardial fibrosis, GJ and cytoskeletal remodeling, which may lead to a detrimental 
arrhythmogenic phenotype and ultimately heart failure113.  
More recently it has been suggested that hypertension associated LVH may not be due to 
pressure overload alone, but that neurohormonal factors can exert trophic effects and ECM 
deposition which may play an import part in the establishment of cardiac hypertrophy114. These 
neurohormones include angiotensin II, aldosterone, norephinephrine, and insulin114. They 
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directly stimulate cardiac hypertrophy and protein synthesis by stimulating the production of 
cytokines and growth factors114.  
Meanwhile, genetic factors have also been hypothesized to play a role in LVH because there is a 
considerable amount of interindividual variability associated with a hypertensive phenotype and 
increases in left ventricular mass111. For example, large cohort studies show that only 50% of the 
variability in left ventricular mass can be explained by increased systolic blood pressure and 
other associated risk factors110. Furthermore, it has been found that the extent of cardiac growth 
in response to pressure load is not uniform among patients experiencing hypertension. Therefore, 
these data, as reviewed by Drazner et al. suggest the presence of an unknown, unmeasured risk 
factor111.  
Another important consideration is the regulation and/or suppression of cardiac hypertrophy via 
different effector molecules. Increasing amounts of evidence show that NO may act through the 
Ca2+/calcineurin-NFAT cascade to suppress the hypertrophic signal that causes cardiomyocyte 
enlargement112.  As well, it has been shown that cardiac remodeling in response to pressure 
overload is inhibited by the NO-cGMP pathway112.  
1.8.2 Hypertension induced endothelium dysfunction  
The endothelium is the innermost lining of a blood vessel and plays a critical role in maintaining 
normal physiology. It is involved in a number of processes including barrier function, regulation 
of vascular tone, neutrophil recruitment, and hormone trafficking115. Endothelial dysfunction 
may be defined as a diminished capacity of the endothelial cells to produce nitric oxide and other 
vasodilators and/or an increase in the production of endothelium-derived vasoconstrictors. 
Functionally, this imbalance leads to impairments in endothelium-mediated vasodilation115. At 
the molecular level endothelial dysfunction is characterized by pro-thrombotic, pro-
inflammatory, and pro-constrictive changes in the endovascular tissue116. Hypertension and 
endothelial function are entwined, wherein hypertension may lead to endothelium dysfunction or 
vice versa. In fact, it has been previously reported that increasingly hypertensive phenotypes 
presented with decreased endothelial function and that this response was graded116. These 
experiments were performed in both men and women by measuring brachial artery reactivity 
while co-administering antihypertensive therapy116. It is also worth noting a study performed by 
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Hamasaki et al. that found that only patients with both hypertension and LVH presented with 
coronary endothelial dysfunction, however endothelial responses in patients with hypertension 
without LVH were similar to those of normotensive individuals117.  
Several mechanisms have been implicated in the development of hypertension mediated 
endothelium dysfunction including: excessive reactive oxygen species (ROS) production, and 
local vascular and systemic inflammation118, 119. In brief, endothelium dependent vasodilation was 
assessed while mouse carotid arteries were exposed to increasing intraluminal pressure118. It was 
found that under increasing pressure there was a parallel decrease in vasodilation and an 
upregulation in nicotinamide adenine dinucleotide phosphate oxidase activity118. In addition it 
has been found that the anti-inflammatory interleukin-10 diminishes endothelium dysfunction in 
experimentally induced hypertensive animals advocating for the adverse role of inflammation in 
the development of this pathology119.  
1.9 Synopsis of the cardiovascular phenotypes found in Cx40 
and Panx1 null mice  
1.9.1 Cx40 null mice  
There are two global Cx40 knockout mouse models central to the cardiac gap junction field, 
which were engineered in the laboratories of Dr. Klaus Willecke, and Dr. David Paul. Both of 
these Cx40 null mice possess similar cardiac physiology including decreased conduction 
velocities due to increased P-wave and QRS-complex duration, and a normal basal heart rate49, 50, 
120, 121. The altered cardiac physiology found in these mice has been hypothesized to be due to the 
inability of the atria and conduction system to fully compensate for the loss of this GJ channel 
protein120, 121. Furthermore, Cx40 ablation leads to altered electrical foci and the inability of the 
myocardium to correctly propagate action potentials, Ca2+ waves, and function as a syncytium122. 
However there is one caveat as only the Willecke Cx40-/- mouse model has been reported to have 
an arrhythmogenic phenotype49. Although the mice were designed in the same manner, this 
discrepancy could be due to slightly different mouse backgrounds, the amount of backcrossing 
that was performed, or due to the fact that the measurements performed not sufficiently sensitive 
(3-lead ECG and 6-lead ECG)49, 50.  
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The cardiac structure of the Cx40-/- mouse was assessed and a mild ventricular septation defect, 
and decreased pre and postnatal survival were reported. It was found that offspring of single 
Cx40 knockout dams had increased in utero death between E11.5 and E13.5 and that 16% of 
newborns died shortly after birth49. The authors hypothesized that embryonic death was due to 
functional rather than structural factors, and that postnatal fatalities were due to septatation 
defects and the improper establishment of pulmonary circulation at birth49. 
Along with cardiac abnormalities, Cx40 knockout mice (both global and endothelial/kidney 
specific knockout models) present with pathophysiological alterations in the vasculature and 
renal system. To summate previous studies it was found that Cx40 ablation led to a perturbed 
renin-angiotensin-aldosterone system, increased renin release, and consequently arterial 
hypertension98 99, 100. As well, Cx40 transgenic mice have irregular perturbed smooth muscle 
calcium dynamics and irregular arteriole vasomotion, characterized by decreased vasorelaxation 
in response to endothelium derived agonists41, 79.  
The Cx40-/- mouse model generously provided to our laboratory was engineered using a targeted 
vector approach. A herpes simplex virus thymidine kinase cassette driven off of a 
phosphoglycerate kinase promotor targeted a portion of exon 2 of the Cx40 gene for deletion120. 
A neomycin resistance cassette driven by the phosphoglycerate kinase promotor was inserted in 
its place120. We decided to proceed with the David Paul knockout mouse due to the fact that this 
model has been extensively characterized in terms of both cardiac and vascular physiology.  
1.9.2 Panx1 mutant mouse models  
Over the past decade at least 5 different mutant mouse lines have been generated to knockout 
Panx1 expression as reviewed by Hanstein et al. 14, 123. Our global Panx1-/- was generated via the 
deletion of exon 2 using Cre-Lox recombination technology by Dr. Vishva Dixit at Genentech124 
and has been utilized in multiple studies, although the cardiovascular system of this mouse has 
yet to be characterized70,126,127,128. As this thesis is concerned with the cardiovascular 
characterization of the Panx1 transgenic mouse line findings relevant to this aim will be 
discussed. 
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The cardiac physiology of the Panx1-/- (Monyer) mouse was recently defined by Petric et al. 
(2016), and is currently the only study to assess the roles of this large-pore channel protein in the 
heart.  They found the hearts of Panx1-/- mice to be normal in weight, size, cardiomyocyte 
arrangement, free from excess fibrosis, and that all functional cardiodynamics as measured by 
echocardiography were similar to wild-type54. As well, electrocardiogram studies revealed that 
this mouse showed a normal heart rate, a prolonged QT interval, higher incidences of AV-block 
only at lower heart rates, and an increased susceptibility to atrial arrhythmias after burst 
stimulation54. This study is in line with previous speculations that Panx1 may contribute to slow 
wave calcium signaling within the heart, and that alterations in these dynamics could lead to 
arrhythmias55.  
 An inducible model in which Panx1 was selectively ablated from smooth muscle cells was 
created and the effects of Panx1-/- on the vasoconstriction were studied. It was found that the 
deletion of Panx1 lowered blood pressure creating a slightly hypotensive phenotype, and that 
vasoconstriction to PE was reduced in the TDA indicating that Panx1 may be involved in α1-
adrenoreceptor mediated vasomotor response in resistance arteries70,104. Alternatively conduit 
arteries have been found to have impaired vasorelaxation to endothelium derived relaxation 
factors such as acetylcholine due to a blunted EDHF response38,125.  
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1.10 Rational, Hypothesis, and Objectives 
Due to the overlapping roles of Cx40 and Panx1 large-pore channels in multiple processes in the 
cardiovascular system from slow wave Ca2+ signaling to the regulation of vascular tone, 
modulation of blood pressure, and involvement in arrhythmogenic pathology, it was postulated 
that these channel proteins might have co-regulatory roles. Interestingly, both Panx1 and Cx40 
are localized to similar locations in the cardiovascular system including the atria and the 
endothelium of the aorta. Hence, due to their similar ability to regulate homeostatic processes 
and comparable localization profiles, we speculated that the ablation of these two channels could 
lead to severe cardiovascular phenotypes, as these channels appear to engage in important cross-
talk mechanisms. Thus the engineering and characterization of a novel global knockout mouse 
model in which both Cx40 and Panx1 channels are ablated will allow for an increased 
understanding of the roles that these two large-pore channels play in the heart and vessels in both 
health and disease.  
Due to the lack of knowledge on this topic this thesis will aim to examine the function of Cx40 
and Panx1 individually and elucidate their potential for overlapping functions within the 
cardiovascular system by using single Cx40 and Panx1 null mice and a novel Cx40/Panx1-double 
knockout mouse. In addition the Cx40-/-Panx1-/- mouse will be characterized for survival and any 
overt phenotypes, as it is the first global Cx/Panx knockout mouse model of its kind.  
It is hypothesized that the ablation of Cx40 and/or Panx1 will lead to reduced mutant mouse 
survival and dysregulated cardiovascular function in vivo. 
 My aims are:  
1. To characterize the phenotype and survival of mice lacking Panx1, Cx40 and 
Panx1/Cx40.  
2. To determine if mice lacking Panx1 and/or Cx40 suffer from cardiac hypertrophy and 
fibrosis.  
3. To assess if mutant mice are subject to hypertension and dysregulated vasomotor 
responses. 
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Chapter 2  
2 Decreased Survival and Increased Hypertension in Mice 
Lacking Both Cx40/Panx1 
Connexins (Cxs) and pannexins (Panxs) are large-pore channel forming proteins that participate 
in cell signalling via the passage of small molecules. Given their potential for overlapping cell 
signaling functions, we proposed that mice lacking both a Cx and a Panx would have a severe 
phenotype. In particular, Cx40 and Panx1 have been reported to potentially share functional 
overlap in the cardiovascular system where they are both expressed.  Thus, we crossed Panx1 
null mice with Cx40 knockout mice and characterized the first global connexin/pannexin double 
knockout mice. All studies performed were carried out on Cx40-/-Panx1-/- mice and compared to 
wild-type mice or mice lacking Cx40 or Panx1.  Mice lacking both Cx40 and Panx1 were fertile 
but ~50% of the pups died either in utero or as newborns.  Both Cx40-/- and Cx40-/-Panx1-/- mice 
exhibited cardiac hypertrophy and a slight increase in cardiac fibrosis. Surprisingly, tail-cuff 
blood pressure measurements of conditioned or anaesthetized mice devoid of Panx1 or Cx40 
were found to be hypertensive with hypertension being increasingly elevated in mice lacking 
both Cx40 and Panx1. Interestingly, mice null for Panx1 did not exhibit the accompanying 
cardiac hypertrophy seen in Cx40-/- and Cx40-/-Panx1-/- mice. Furthermore, the combined ablation 
of Cx40 and Panx1 decreased endothelium-dependent vasodilation characteristic of endothelial 
dysfunction.  Overall, these studies suggest that even though Panx1 and Cx40 may act via 
differential mechanisms, they have a co-regulatory role in vascular response. 
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2.1 Introduction  
Normal cellular function, organ development, homeostasis, and repair after damage relies 
heavily on the initiation of a myriad of critical signaling networks and the interaction of 
extracellular, intercellular and intracellular cascades1. The connexin (Cx) and/or pannexin (Panx) 
families of large-pore forming channel proteins facilitate the passage of various ions, nucleotides 
and secondary messenger molecules such as calcium, adenosine triphosphate (ATP), and inositol 
triphosphate (IP3) either between cells or between a cell and the extracellular milieu2. Connexins 
may act in either intracellular signaling as functional hemichannels, although this is not well 
documented in vivo, or more classically form gap junction (GJ) channels for direct intercellular 
communication3. On the other hand, pannexins typically exist at the cell surface as large-pore 
channels that function in extracellular signaling4. It is the interplay between these key-signaling 
modalities that allow critical cellular cascades to govern many functions of the heart and 
vasculature5.  
The heart requires cell-cell communication for the spread of electrical activity, the propagation 
of action potentials, and the synchronized contraction of the myocardial tissue6. The primary 
connexin family members present in the heart are Cx43, Cx40, and Cx457. Interestingly in the 
murine heart, Cx40 is developmentally regulated with peak expression throughout the entire 
heart at embryonic day 14 before its expression is confined to the developing atria and 
conduction system8. Cx37, Cx40, and Cx43 present within the vasculature allow for the coupling 
of endothelial cells and vascular smooth muscle cells at the myoendothelial junction, the 
alteration of vasomotor responses, and the propagating slow Ca2+ waves9. For example in the 
renal vasculature, Cx40 and extracellular ATP are key mediators of slow wave calcium signaling 
between endothelial cells. Slow wave Ca2+ signaling acts not only in vasodilation of the vessels 
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to control glomerular filtration rate, but may also play an important role in renin synthesis and 
release10, 11.  Characterization of a Cx40 global knockout mouse revealed myocardial 
hypertrophy, fibrosis, arrhythmias, and increased P-wave and QRS complex duration12, 13. 
Furthermore, these animals suffer from renin/angiotensin-mediated hypertension and perturbed 
smooth muscle calcium dynamics14.  
Panx1 is the most prevalent pannexin family member expressed in the cardiovascular system, 
and is found in cardiomyocytes, endothelial cells, and smooth muscle cells15. The abundance, 
localization and function of Panx1 within the heart are not well characterized. However, it is 
known that Panx1 acts as a major ATP release channel in cardiomyocytes following injury or 
inflammation16.  As well, Panx1 may contribute to inter- and intra- cellular slow wave calcium 
signaling via extracellular purinergic signaling in order to amplify Ca2+ release from intracellular 
stores17. In the vasculature, Panx1 has been implicated in altered vasomotor responses in large 
arteries by regulating endothelium-derived hyperpolarizing factor18 and in small resistance 
arteries by modulating vasoconstriction19. The ability of Panx1 channels to regulate vasomotor 
responses is due to their ability to act as an ATP release channel in order to modulate α-
adrenergic and slow wave Ca2+ signaling under differential physiological conditions20, 21, 22. In the 
heart, it has been reported that Panx1-/- mice have an increased incidence of AV-block, a 
prolonged QT interval and an increased risk of atrial fibrillation after burst stimulation23. 
Furthermore, the Panx1 knockout mouse has been shown to possess decreased vasoconstriction 
in resistance arteries exposed to phenylephrine19, and decreased muscarinic receptor mediated 
vasodilation of large arteries18. 
Given that Cx40 and Panx1 appear to play critical roles in the heart and blood vessels, the 
question arouse as to whether mice that globally lacked both of these large-pore channel proteins 
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would even survive, and if so, would they exhibit a severe cardiovascular phenotype.  Currently 
there is only one other Cx/Panx double knockout mouse in existence where the conditional 
ablation of Cx43 and Panx3 lead to defective osteogenesis where both of these channel proteins 
are highly expressed24. In the current study we found approximately half the mice lacking both 
Cx40 and Panx1 did indeed survive, were fertile, exhibited a normal lifespan, and showed no 
overt phenotype. That being said, we discovered that Cx40-/-Panx1-/- mice had fewer offspring 
due to death in utero, and decreased post-natal survivability.  With respect to the cardiovascular 
system, Cx40-/-Panx1-/- mice were found to have cardiac hypertrophy and mild fibrosis. 
Interestingly, tail cuff blood pressure measurements revealed that mice lacking Cx40, Panx1 or 
both Cx40 and Panx1 were hypertensive and exhibited a decreased endothelium-dependent 
vasodilatory response, which was exaggerated in mice devoid of both Cx40 and Panx1.  
2.2 Materials and Methods 
2.2.1 Engineering and Characterization of Mice  
 Cx40-/-Panx1-/- mice were bred in house from Cx40-/- and Panx1-/- single knockout mice that had 
been previously backcrossed onto a C57BL/6N background for several generations. The Cx40 
knockout mouse was generated by Simon et al. and was a generous gift from Dr. David Paul via 
Dr. Donglin Bai (University of Western Ontario, London, ON)13.  Panx1 null mice were provided 
by Dr. Vishva Dixit at Genentech and have been previously characterized by Qu et al25. Wild-
type mice of the C57BL/6N strain from Charles River were used as controls. Mice were housed 
4 per cage, received food and water ad libitum, and were maintained on a 12 hour light/dark 
cycle at 24°C. PCR genotyping was performed to ensure the ablation of Cx40 and Panx1 as 
described previously using ear clip DNA as a template25, 26. For the characterization of male 
mouse weight/size, mutant and wild-type mice from 3-6 litters, with a minimum of 10 mice per 
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timepoint, were weighed periodically for up to a year. During tissue collection all animals were 
sacrificed via cervical dislocation, and organs were fixed in formalin or flash frozen and stored at 
-80°C. All studies performed were in accordance with the Animal Care Committee of Western 
University. 
2.2.2 q-PCR Analysis  
RNA was extracted using the Qiagen RNeasy kits (Qiagen) from the atria and ventricle of 3 
month old wild-type and Panx1-/- mice. cDNA was synthesized using the first-strand cDNA 
synthesis kit (SuperScript VILO). Panx1 transcript levels were determined using mouse Panx1-
specific primers (5'ACAGGCTGCCTTTGTGGATTCA3'; 5' GGGCAGGTACAGGAGTATG3') 
and the PowerUp SYBR green Mastermix (Life technologies) in a Bio-Rad CFX96 real-time 
system. Results were normalized to 18SrRNA. Brain tissue was used as a positive control as it 
expresses abundant levels of Panx1 transcript, and tissues from Panx1-/- mice were included with 
wild-type tissue as a negative control. N = 3 per group.  
2.2.3 Litter Size Characterization  
 Litter sizes of wild-type and mutant mice were tracked by setting up multiple breeder cages for 
each strain and counting the number of offspring per litter at birth and 3 days post-natal (N=12 
litters, approximately 5-10 mice/litter). Survivability was calculated wherein the amount of pups 
alive 3 days post birth was compared to the number of pups at birth. Furthermore fertility and 
incidences of in utero death were assessed in the Cx40-/-Panx1-/- double knockout mouse by 
counting the number of implantations, resorption sites, and in utero death (N=7 dams) prior to 
day 14.5. For timed pregnancies, E0.5 was taken as the morning on which a vaginal plug was 
found.   
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2.2.4 Heart Weight Characterization 
 Three week and 3 month old mice were euthanized via cervical dislocation, and their hearts 
were excised. Dry heart weights were then recorded and normalized to the initial mass of the 
animal to obtain a normalized heart weight (mg/kg N=6 hearts per group). 
2.2.5 Western Blot Analysis 
 Tissue lysates of mutant and wild-type hearts were prepared via homogenization of atria, or 
whole hearts on ice in lysis buffer (150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-
100, 10 mM Tris-HCl) with protease and phosphatase inhibitors (Roche-Applied Sciences; 100 
mM NaF and 100 mM Na3VO4). 30 μg of protein from lysates were resolved on a 10% SDS-
PAGE gel and then transferred to a nitrocellulose membrane using an iBlot Dry Blotting system 
(Invitrogen). Membranes were blocked in a 3% bovine serum albumin/0.05% Tween20 PBS 
solution (PBST) for 30 minutes at room temperature.  Membranes were then exposed to the 
following primary antibodies: rabbit anti-Cx43 (1:5000, Sigma, C 6219) goat anti-Cx40 (1:500, 
Santa Cruz, sc-20466); mouse anti-collagen 1 (1:500, Abcam, ab34710), rabbit anti-fibronectin 
(1:500, Abcam, ab2413), mouse anti-N-cadherin (1:200, BD Signal Transduction, 610920), and 
mouse anti-GAPDH (Santa Cruz, sc-365062), diluted in blocking solution at 4°C overnight. 
Membranes were then washed 3 times for 5-minute intervals with PBST. Fluorescent-tagged 
secondary anti-rabbit Alexa Fluor® 680 (1: 5000, LICOR Biosciences, ab175772) or anti-mouse 
IRdye 800 (1:5000, Rockland Immunochemicals, Inc., 610-132-003) were then used to detect 
primary antibodies. Blots were then imaged using Odyssey Infrared Imaging System (Li-Cor 
Biosciences) and densitometry analyses was performed wherein samples were normalized to 
GAPDH loading controls. N=4 samples per group. 
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2.2.6 Immunofluorescence Microscopy 
 Immunofluorescence was performed as previously described27. Briefly, 10% formalin fixed 
paraffin embedded heart sections (7 µm) were deparaffinized, antigen retrieved in Vector 
Antigen Unmasking Solution (Vector Labs), and then rinsed with PBS. For cryosections (10 μm) 
hearts were fixed in formalin fixative overnight and then cryoprotected in a 30% sucrose solution 
prior to sectioning. Sections were blocked in 3% BSA/0.1% Triton X-100 for 1 hour at room 
temperature. Sections were probed overnight at 4°C using the primary antibody dilutions: rabbit 
anti-Cx43 (1:1000, Sigma, C 6219); goat anti-Cx40 (1:200, Santa Cruz, sc-20466). Secondary 
Alexa Fluor® 555-conjugated anti-rabbit, anti-mouse or anti-goat (1:500, Molecular Probes, 
A21425, A21429 or A21431) and Alexa Fluor® 488-conjugated anti-rabbit or anti-mouse (1:500 
dilution, Molecular Probes, A11008 or A11017) was applied for 1 hour at room temperature to 
detect primary antibody binding. Hoechst (1:10, 000) was applied for a 10-minute period to label 
nuclei (1:1000 in ddH2O). Coverslips were mounted with Airvol and imaged using the Zeiss 
LSM 800 confocal microscope.   
2.2.7 Quantification of Cardiomyocyte Area 
 Cross sections (20 μm) of formalin fixed left atria and ventricle of wild-type, Cx40-/-, Panx1-/-, 
and Cx40-/-Panx1-/- mice were deparaffinized, and stained with wheat germ agglutinin (1:10, 000, 
ThermoFisher, W11261), diluted in PBS, to visualize sarcolemma membranes28. Airvol was used 
to mount coverslips and slides were then imaged using the Zeiss LSM 800 confocal microscope 
using a 40x lens. Images from all four genotypes were blinded to the investigator and quantified 
by measuring myofibril area by encircling cell membrane borders in Image J.  
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2.2.8 Cardiac Fibrosis Assessment  
Longitudinally sectioned hearts all mouse genotypes (7 μm) were deparaffinized and stained 
with Masson’s Trichrome using standard procedures to analyze the extent of cardiac fibrosis. 
Light microscopic images from the left atrial and left ventricular wall were analyzed for 
interstitial and perivascular collagen deposition29. 
2.2.9 Heart Rate and Blood Pressure Recordings 
Heart rates, systolic and diastolic blood pressures were recorded from male 3-month-old 
conscious mice from all four genotypes using the CODA tail-cuff blood pressure system (Kent 
Scientific, Torrington, CT, USA) as previously described30, 31(N=9). Briefly, mice were placed 
into restraint tubes and the tail cuff was positioned at the base of their tail. Mice were than given 
30 minutes to acclimatize before initiating the measurements, and 3 trials of preconditioning 
were performed before measurements were used to account for anxiety effects. To further 
account for the influence of anxiety on blood pressure and heart rate, measurements were also 
taken on anesthetized mice (ketamine 100 mg/kg and xylazine 10 mg/kg intraperitoneal). 
2.2.10 Vasomotor Studies 
Vascular reactivity in wild-type, Cx40-/-, Panx1-/-, and Cx40-/-Panx1-/- mice was assessed by 
performing isometric tension experiments on a wire myograph (DMT) as previously described32, 
33. 3-4 month old mice were sacrificed via cervical dislocation, thoracic aortas were excised, 
cleaned, cut into 2 mm rings, and mounted in organ bath chambers containing 5 mL of 37°C 
oxygenated KREBS buffer (in mmol/l: 130 NaCl, 14.9 NaHCO3, 10.0 glucose, 4.70 KCl, 1.17 
MgSO4, 1.18 KH2PO4, 1.60 CaCl2, and 0.027 EDTA). Contractile responses to phenylephrine (1 
nM to 30 μM), and KCl (10 to 100 mM) were recorded in vessels stretched to a passive resting 
50 
 
tension of either 1000 or 1250 mg (determined in preliminary experiments). Similarly, dilatory 
responses were assessed with either methacholine (0.1 nM to 30 μM) or sodium nitroprusside 
(0.01 nM to 30 nM) in phenylephrine (10 μM) pre-contracted rings.  
2.2.11 Statistical Analysis  
 Results are provided as means ± SEM.  Student’s t tests, one-way ANOVA, and repeated 
measures ANOVA with a post hoc Tukey test were used to evaluate statistical differences 
between treatment groups for various experiments. All statistical analyses were performed using 
graphpad. Values where p < 0.05 were deemed statistically significant. 
2.3 Results  
2.3.1 Mice lacking Panx1 and/or Cx40 are similar in size and weight 
To evaluate the levels of Panx1 present in the wild-type mouse heart, RNA was extracted from 
atrial and ventricular tissues and subjected to q-PCR analysis. Panx1 transcripts were abundant in 
both the atria and the ventricles, not unlike observations in brain tissue. Moreover, evaluation of 
Panx1 transcript levels from Panx1 null mice revealed that Panx1 was ablated from the heart and 
brain (Figure 2.1A). PCR genotyping further revealed that both Cx40 and Panx1 were ablated 
from the double knockout mouse generated from crossing Panx1 null mice with mice lacking 
Cx40. The presence of Cx43 mRNA in control and mutant mice confirmed the integrity of the 
samples used in genotyping (Figure 2.1B). In order to determine if mice lacking Panx1, Cx40 or 
both Panx1 and Cx40 exhibited any overt phenotypes, we tracked the size and weight of all 
mouse genotypes. It was found that all four-mouse genotypes exhibited no differences over a 1-
year time frame (Figure 2.1C, D). 
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2.3.2 Increased in utero and newborn pup death in Cx40-/-Panx1-/- mice  
Although no overt anatomical phenotypes were found, the Panx1 and Cx40 double knockout 
mouse produced 33% fewer pups per litter than wild-type control animals (Figure 2.2A). The 
survivability ratio revealed that 36% more Cx40-/-Panx1-/- pups die 1-3 days post birth than single 
knockout mice and wild-type controls (Figure 2.2B). Therefore, between embryonic and 
newborn pup death Cx40-/-Panx1-/- litter sizes are decreased by 69%. Pregnant dams were 
dissected on embryonic day (E) 14.5 to delineate if the in utero death was due to resorption, early 
embryonic death (prior to E14.5) or late fetal death. We found that the Cx40-/-Panx1-/- embryos 
had a similar number of implantations and percent resorption compared to wild-type mice 
(Figure 2.2C, D). Interestingly, 18% of in utero death in Cx40-/-Panx1-/- mice was found to occur 
at E14.5 (Figure 2.2E). These results indicate that Cx40-/-Panx1-/- mice die both prematurely in 
utero and soon after birth.  
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Figure 2-1 Characterization of Cx40/Panx1 knockout mice. 
(A) Quantitative PCR revealed that Panx1 was highly expressed in both the atrial and ventricles 
of wild-type (WT) mice, similar to that found in brain tissue, but absent in Panx1 null mice. (B) 
PCR genotyping confirms that both Panx1 and Cx40 are ablated in double knockout mice as 
reveled in lanes 2-5. Cx43 was present in all mice and the insertion of the Cx40 neocassette 
(Cx40-NC) reaffirms the ablation of Cx40. (C) Photograph shows that the overall size of control 
and mutant mice are approximately the same. (D) Assessment of mouse weight over 1 year 
revealed that all control and mutant mice have similar weights and weight gain (N= 3-6 litters, 
10 mice/timepoint). 
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Figure 2-2 Cx40/Panx1 null mice have decreased survival in utero and postnatal 
 (A) WT and genetically-modified mouse mean litter size at birth and (B) survivability 3 days 
postnatal (N=12 litters). (C) Mean number of implantations, (D) % fetal resorption, and (E) % 
fetal deaths in utero prior to E14.5 for WT and Cx40-/-Panx1-/- mice  (N=7 damns). *p<0.05, 
***p<0.001, ns = not significant.  
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2.3.3 Ablation of Panx1 does not alter the expression/distribution of 
Cx40 
In order to determine if there was potentially regulatory cross-talk between Cx40 and Panx1 
channels, we assessed if the ablation of Panx1 altered the expression or distribution of Cx40.  
Immunofluoresence revealed the presence of Cx40 in GJ structures in the atria of wild-type and 
Panx1-/- mice which was appropriately absent from hearts obtained from Cx40 knockout mice 
(Figure 2.3A).  Western blots further revealed that there was no quantitative change in Cx40 
levels in mice lacking Panx1 (Figure 2.3B, C).  Thus, Cx40 levels or localization does not 
change in mice lacking Panx1.  
2.3.4 Cx40-/- and Cx40-/-Panx1-/- mouse hearts are hypertrophic  
Given the enlarged appearance of Cx40-/- and Cx40-/-Panx1-/- mouse hearts (Figure 2.4A), it was 
not unexpected that both these mutant mice had higher heart mass compared to Panx1-/- and wild-
type mice at 3 weeks (Figure 2.4B) and 3 months (Figure 2.4C) of age. Left and right kidney 
weights were also assessed and found to be similar among all four genotypes (Figure 2.4D). To 
validate that the increased heart mass seen in the Cx40-/- and Cx40-/-Panx1-/- mice was due to 
cardiomyocyte hypertrophy, myofibril area was measured after denoting the boundaries of the 
cells by labeling with wheat germ agglutinin. Representative micrographs of atrial (Figure 2.5A) 
and ventricular (Figure 2.5B) cross-sections of myofibril bundles in 3-month-old mice and 
quantitation revealed that cell area   
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Figure 2-3 Cx40 levels and localization are unchanged in Panx1 ablated mice. 
(A) Fluorescent micrographs reveal similar localization of Cx40 (green) in WT and Panx1-/- 
mouse atria. The absence of Cx40 gap junction plaques in Cx40-/- and Cx40-/-Panx1-/- confirms 
the ablation of Cx40. (B) Western blot and (C) quantification reveals similar levels of Cx40 in 
wild-type and Panx1-/- mice, and its ablation in Cx40-/- and Cx40-/-Panx1-/- atria (N=3). Scale bar= 
20 µm. 
58 
 
W
T#
Cx
40
(/(
#
Pa
nx
1(
/( #
Cx
40
(/(
Pa
nx
1(
/( #
GAPDH#
Cx40#
B" C"
##
#
#35(#
#
#
35(#
W
T
Cx
40
'/'
Pa
nx
1'
/'
Cx
40
'/' Pa
nx
1'
/'
0.0
0.5
1.0
1.5
Cx
40
/G
AP
D
H
WT############## Cx40(/(########## Panx1(/(# Cx40(/(Panx1(/(##
A"
59 
 
  
 
Figure 2-4 Increased heart mass found in Cx40 and Cx40/Panx1 knockout mice. 
(A) Photographic examples of representative hearts from all mouse cohorts highlighting the 
enlarged hearts in Cx40-/- and Cx40-/-Panx1-/- mice. When heart weights were examined it was 
found that Cx40-/- and Cx40-/-Panx1-/- mice had increased heart weight relative to body weight at 
the ages of (B) 3 weeks (N=4) and (C) 3 months (N=6) as compared to WT and Panx1-/- mice. 
(D) Mean kidney weights were compared in 3 month old mice and found to be similar (N= 6). 
Different letters represent significant changes, p<0.001. ns = not significant 
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Figure 2-5 Cx40 and Cx40/Panx1 mice have hypertrophic cardiomyocytes. 
Wheat germ agglutinin staining (red) of the cardiomyocyte cell surface in left (A) atrial and (B) 
ventricular heart cross sections taken from 3-month old wild-type and mutant mice. 
Quantification of the average cardiomyocyte cell circumference revealed increased (C) atrial 
(N=6) and (D) ventricular (N=5) cardiomyocyte area in Cx40-/- and Cx40-/-Panx1-/- mouse hearts, 
p< 0.05. Scale bar = 20 µm. 
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was significantly increased in the left atria (Figure 2.5C) and left ventricle (Figure 2.5D) of Cx40 
and Cx40/Panx1 knockout cohorts of mice.  
2.3.5 Fibrotic and structural analysis of mutant mouse hearts 
Cardiac fibrosis in 3-month-old wild-type and mutant mouse hearts was assessed via Masson’s 
Trichrome staining and Western blotting for various extracellular matrix (ECM) proteins. 
Masson’s Trichrome staining of the left atria (Supplementary Figure 2.1A) and ventricle 
(Supplementary Figure 2.1B) suggested that there was minimal interstitial fibrosis in the left 
ventricle of both single knockouts, and double knockout mice. Immunoblotting indicated similar 
levels of collagen 1 and fibronectin present in the atria and entire heart among all four genotypes 
(Supplementary Figure 2.1 C, D). Overall findings are similar among all four genotypes with 
little to no fibrosis present.  
Since heart hypertrophy and fibrosis are indicators of cardiovascular disease wild-type, Cx40-/-, 
Panx1-/-, and Cx40-/-Panx1-/- hearts were examined for structural anomalies. Localization of Cx43 
plaques to the intercalated disc in the atria (Figure 2.6A) and ventricles (Figure 2.6B) in mutant 
mice were comparable to wild-type. To assess for compensatory effects by the upregulation of 
other connexins, immunoblotting revealed that the levels of Cx43 were similar in the atrial tissue 
of knockouts and wild-type mice (Figure 2.6D). Western blotting for   N-cadherin (Figure 2.6E) 
revealed similar levels of this junction protein among all four genotypes. These results indicate 
that the loss of Cx40, Panx1 or both had no detrimental effects on the structure of the intercalated 
disc. Finally, myofibril arrangement was evaluated by phalloidin staining (Figure 2.6C) and it 
was found that F-actin structure was comparable among all four genotypes. 
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Figure 2-6 Junctional proteins and F-actin are unaltered in the hearts of mutant mice. 
In 3-month-old wild-type, Cx40-/-, Panx1-/-, and Cx40-/-Panx1-/- mice Cx43 (green) localization 
was assessed by immunofluorescence in the (A) atria and (B) ventricles. (C) Phalloidin (red) was 
used to visualize F-actin in the ventricle of WT and mutant mice. (D) Western blots of Cx43 and 
(E) N-cadherin in atrial lysates revealed no difference in the abundance of these junctional 
proteins (N=3). Scale bar = 20 µm. 
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2.3.6 Physiology of the cardiovascular system in mutant mice   
To begin to characterize the cardiovascular physiology of the mutant mice, blood pressure testing 
via the Coda tail-cuff system was performed on all four genotypes at 3 months of age. Somewhat 
to our surprise, we discovered that Cx40-/- and Panx1-/- mice were both hypertensive, and mice 
lacking both large-pore channels were more severely hypertensive (Figure 2.7A). To confirm 
that the hypertension observed was not due to experimentally-induced anxiety, blood pressure 
measurements of anesthetized mice were performed and it was found that the three knockout 
strains remained hypertensive while the wild-type mice were normotensive  (Supplementary 
Figure 2.2A). Furthermore, heart rates (HR) were measured and found to be comparable among 
all four genotypes ranging from a mean HR of 598 beats per minute (BPM) in wild-type mice to 
630 BPM in the Cx40-/-Panx1-/- mouse (Figure 2.7B). Interestingly, heart rates in anesthetized 
mice were variable, and it is speculated that this was due to individual differences in drug 
metabolism (Supplementary Figure 2.2B). 
To determine if the aortic vasomotor signaling properties were affected by the ablation of Cx40 
and/or Panx1 from endothelial cells, or if the hypertension found in the mutant mice caused 
endothelial damage, isometric tension experiments were performed on aortic rings using a wire 
myograph. Four parameters were assessed; vasocontractile responses to phenylephrine (PE) and 
to potassium chloride (KCl) agonists, and vasodilation to methacholine (MCh) and sodium 
nitroprusside (SNP) agonists. It was found that contractile responses to PE and KCl were similar 
amongst mutant and wild-type mice (Figure 2.8A, B). Contrastingly, MCh mediated vasodilation 
was significantly decreased in Cx40-/-, Panx1-/-, and Cx40-/-Panx1-/- mice after the addition of 100 
nM or more of agonist. Nevertheless, receptor independent vasodilation as assessed by SNP was 
unaltered among all four genotypes (Figure 2.8C, D).   
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Figure 2-7 Panx1 and Cx40/Panx1 mice are hypertensive. 
(A) Tail-cuff hypertension testing revealed that mutant mice have significantly higher systolic 
and diastolic blood pressure than wild-type mice, with the double knockout of Cx40 and Panx1 
having an additive effect (N=9). (B) Mean heart rate is similar among all four genotypes (N=9). 
One-way ANOVA, a, b, c, d = p<0.001. 
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Figure 2-8 Endothelium-dependent vasodilatory responses are blunted in mutant mice. 
Time course dose response curves to (A) phenylephrine (PE) and (B) potassium chloride (KCl) 
were generated to assess thoracic aorta contractility and to (C) methacholine (MCh) and (D) 
sodium nitroprusside (SNP) to assess aorta vasodilation among 2-4 month old wild-type, Cx40-/-, 
Panx1-/-, and Cx40-/-Panx1-/- mice. *p<0.05.  
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2.4 Discussion  
Both Panx1 tissue-specific and global knockout mice have been engineered in recent years to 
assess the roles of these large-pore channels in normal physiology and disease34, 35. Through these 
studies Panx1 has emerged as an important player in cardiovascular physiology. This point was 
emphasized when Petric et al.  reported high levels of Panx1 within murine atria, and that Panx1 
ablation led to increased susceptibility to atrial fibrillation23. As well, Panx1 has been implicated 
in α1-adrenoreceptor mediated vasoconstriction19, blood pressure regulation36, and renal 
function37. Interestingly, the gap junction protein Cx40 shares many of these characteristics 
including its abundance in the atria, and involvement in cardiac, vascular, and renal function38, 39. 
Therefore in the current study we addressed the consequences of ablating both Panx1 and Cx40 
channels in the same mouse model as we hypothesized this would lead to an increasingly severe 
cardiovascular phenotype.   
2.4.1 Engineering and phenotyping of mice lacking both Cx40/Panx1 
Our novel Cx40-/-Panx1-/- mouse is the first global knockout mouse model in which a connexin 
and pannexin channel type have been co-ablated, and complements one other similar strategy 
where Cx43 and Panx3 were conditionally ablated in bone tissue24. Since both Cx40 and Panx1 
have been reported to release overlapping small members of the metabolome from intracellular 
stores to the extracellular milieu3,4, we anticipated that the double knockout mouse might have a 
reduced ability to survive. Intriguingly, while double-knockout mice were fertile and viable, the 
combined ablation of Cx40/Panx1 caused a severe reduction in prenatal and newborn pup 
survival. A previous report describes mild pre/postnatal death in the Cx40-/- mouse. Those 
authors hypothesized that prenatal embryo death was due to inadequate propagation within the 
cardiac conduction system, while postnatal pup death was likely a combination of improper 
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septation and increased cardiac workload during the establishment of pulmonary circulation12. 
Similarly, in our study, although not statistically significant, Cx40 null mice had 22% fewer 
offspring and 10% newborn death compared to wild-type. Intriguingly, this phenotype although 
minor in the single Cx40 knockout mouse became detrimental when Panx1 and Cx40 were co-
ablated as over half of the Cx40-/-Panx1-/- litter was lost either to pre or postnatal mortality. These 
findings point towards a concomitant role for Cx40 and Panx1 in the development of the 
maturing embryo. Qualitative evaluation of the dead Cx40-/-Panx1-/- embryos revealed that in 
utero death might be due to insufficient cephalic circulation and hemorrhaging in the thorax. 
This observation points towards a cardiovascular cause for embryonic lethality, and potentially 
to the dynamic regulation of Panx1 along with Cx40 in fetal heart development8.  The 
developmental regulation of Panx1 has been reported in skin40 further suggesting that Panx1 may 
play critical roles in the development of multiple organs.  
2.4.2 Cx40-/-Panx1-/- mice have cardiac hypertrophy due to Cx40 
ablation  
Arterial hypertension is the most common cause of pressure overload within the heart and often 
leads to pronounced cardiac hypertrophy, with the left ventricle being the most severely affected 
heart chamber. Within this organ, hypertrophic growth is due to biomechanical stress, which 
causes cardiomyocyte enlargement by potentiating changes in cardiac gene expression and 
reactivation of the fetal gene program41. This phenomenon has been previously reported in Cx40 
null mice wherein hypertrophic characterization relied exclusively on the quantification of heart 
weight13. Here, we observed cardiac hypertrophy in young and adult Cx40-/- mice and confirmed 
that it was due to the enlargement of left ventricular cardiomyocytes. Contrary to our 
expectations, the phenotype observed in mice lacking both Cx40 and Panx1 was not exacerbated. 
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This indicates that the cardiac hypertrophy found in the Cx40-/-Panx1-/- mouse is unilaterally due 
to the knockout of Cx40 channels. Additionally, both Cx40-/- and Cx40-/-Panx1-/- mice had 
pronounced left atrial cardiomyocyte enlargement. This is intriguing because unlike left 
ventricular cardiomyocyte hypertrophy, which is often associated with a hypertensive phenotype, 
left atrial dilatation may be due to pathologies that arise from defects in the cardiac conduction 
system like atrial fibrillation42 and both the Cx40-/- and Panx1-/- mice are increasingly susceptible 
to atrial arrhythmias13, 23.  
2.4.3 Mutant mouse hearts lack fibrosis & display normal GJ/myofibril 
arrangement  
Hypertrophy-induced myocardial remodeling is characterized by augmented interstitial fibrosis, 
gap junction lateralization, and cytoskeletal remodeling which are alterations that often lead to a 
detrimental arrhythmogenic phenotype and heart failure43. Interstitial fibrosis was only minimally 
identified by Masson’s trichrome staining and there were no significant changes in collagen 1 or 
fibronectin in either the left atria or ventricle of any mice suggesting that mutant mouse hearts 
were not particularly fibrotic. Likewise, the intercalated disc distribution of Cx43 and N-
cadherin, as well as the myofibril arrangement was unaltered in mutant mice. Taken together 
these findings indicate that the cardiac hypertrophy found in single Cx40 and double 
Cx40/Panx1 knockout mice may lead to myocardial remodeling however mutant hearts do not 
yet possess detrimental ECM protein depositions or alterations in intercalated disc integrity that 
would lead to heart failure. Because hypertrophy is often an adaptive physiological process in 
response to increases in cardiac workload, and is dynamically regulated, we speculate that in 
later life, markedly increased fibrosis, gap junction and cytoskeletal remodeling may occur in our 
mutant mice44.  
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2.4.4 Mutant mice are hypertensive and possess altered vasomotor 
responses  
Because the development of cardiac hypertrophy is often secondary to hypertension, tail-cuff 
blood pressure measurements were performed on all mutant mice. The hypertensive phenotype 
of Cx40 knockout has already been reported to be mediated by the renin-angiotensin-aldosterone 
system45. Previous findings of hypotension in an inducible model of selective Panx1 ablation 
from smooth muscle cells led to speculation that the combined ablation of Cx40/Panx1 would 
lead to a more normalized blood pressure36.  Surprisingly, it was found that, along with the Cx40-
/- mice, Panx1 global knockout mice had increased systolic and diastolic blood pressures whether 
mice were awake or anesthetized. Furthermore, hypertension in the double knockout was 
potentiated in awake mice by the combined ablation of Cx40 and Panx1. These results were 
intriguing and unexpected because not only do they point towards a role for Panx1 in blood 
pressure regulation, but also imply that Panx1 may protect the heart from hypertension-induced 
growth. However, since hypertension is a multifactorial disease and all mice used in this study 
were global knockouts, this raised questions as to where Panx1 was contributing to blood 
pressure regulation.  
Hypertension is due to many different factors, which cause alterations in peripheral resistance 
and cardiac output. Peripheral resistance is mediated by small arteries, whereas cardiac output is 
influenced by blood volume, and thus under renal control46.  As of yet the cause of hypertension 
in Panx1 global knockout mouse remains unknown but several possibilities exist.  Extensive 
research previously performed on resistance arteries in a mouse model in which Panx1 was 
selectively ablated from smooth muscle cells indicates that the hypertension observed in our 
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study is not due to increased vasoconstriction of the small arteries themselves but rather a 
consequence of system wide ablation of Panx1 19,36.  
The first possibility involves the participation of Panx1 in endothelium derived hyperpolarization 
factor relaxation. In fact, global Panx1-/- mice display increased resistance due to the blunted 
response of Panx1-/- mouse arterioles to muscarinic receptor agonist acetylcholine47. The second 
possibility involves Panx1 channels on erythrocytes releasing ATP during low blood pO2 to 
stimulate vasodilation. Without this feedback mechanism it is possible that peripheral resistance 
could be increased48.  A third regulatory mechanism that could be absent in Panx1-/- mice and 
govern its hypertension involves altered feedback between the carotid body and brainstem.  In 
short, it has been shown that type II cells in the carotid body propagate ATP released from Panx1 
channels onto afferent nerve terminals that synapse with cardiorespiratory centers in the 
brainstem for the regulation of blood pressure and respiratory rate49. In addition, Panx1 channels 
have been localized in both cortical and medullary tubule segments of the kidney and in the renal 
vasculature. Functionally little is known about the role of Panx1 in the renal system, however 
based on its similar localization profile to Cx30 within the apical collecting duct system, and its 
role in purinergic signaling, it has been previously hypothesized that Panx1 may play a role in 
pressure natriuresis, and that Panx1-/- mice might possess a salt retention phenotype50 and 
consequently hypertension. All in all because there is evidence that Panx1 plays such a diverse 
role in blood pressure regulation it is hard to speculate if one or all of the aforementioned factors 
as a conglomerate are producing the hypertensive phenotype found in the global knockout 
mouse, however selective ablation of Panx1 in these various organ systems using Cre-lox 
technology could help predict causation. We therefore postulate that Cx40 and Panx1 act either 
via similar or different mechanisms to induce hypertension in the double knockout mouse. 
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Another important consideration to address is why the hypertension found in Panx1-/- mice did 
not cause cardiac hypertrophy. More recently it has been suggested that hypertension associated 
left ventricular hypertrophy may not be due to pressure overload alone as large cohort studies 
show that only 50% of the variability in left ventricular mass can be explained by increased 
systolic pressure51. Recently neurohormonal factors that can exert trophic effects via cytokine 
and growth factor production, the NO-cGMP pathway, and genetic factors have come into the 
limelight for their suggested roles in the induction of hypertrophy52, 53. Therefore, these data 
suggest the presence of an unknown, unmeasured risk factor and implicate Panx1 in the 
regulation of cardiac hypertrophy.   
The endothelium also plays a critical role in maintaining normal physiology and is involved in 
the modulation of vascular tone through the balanced release of relaxing and contracting factors. 
In certain cardiovascular pathophysiologies such as hypertension this balance may be disrupted 
which leads to impairments in endothelium –mediated vasodilation and endothelial 
dysfunction54. Both Cx40 and Panx1 are primarily localized to endothelial cells in elastic arteries, 
are implicated in the regulation of arterial tone by acting as facilitators of vasodilation, and both 
Cx40 and Panx1 mutant mice have been found to possess a decreased vasodilatory response in 
conduit arteries55, 56, 57.  Our study demonstrated that the combined ablation of Cx40 and Panx1 
had an additive effect on the impairment of vasodilation but did not produce alterations in 
vasoconstriction. In fact, Cx40-/-Panx1-/- mouse aorta was found to possess severe endothelial 
dysfunction, characteristic of its minimal relaxation response to muscarinic receptor agonist 
MCh but unaltered response to endothelium independent vasodilator SNP. We postulate that the 
drastic decrease in vasodilation seen in the Cx40/Panx1 double knockout mouse is a combination 
of hypertension induced endothelial damage and the combined alteration of multiple 
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endothelium derived vasodilatory pathways most notably nitric oxide mediated signaling in the 
case of Cx4057 and endothelium-derived hyperpolarizing factor in regards to Panx1 ablation47.  
In summary we have engineered and characterized the first Cx/Panx global knockout mouse that 
was bred from mice lacking Cx40 or Panx1 that exhibited distinct cardiovascular phenotypes.  
Consistent with earlier reports, Cx40 knockout mice produced approximately normal litter sizes 
but exhibited pronounced cardiac hypertrophy accompanied by minimal fibrosis, yet no GJ or 
myofibril remodeling. These mice were hypertensive and displayed decreased vasodilatory 
responses to methacholine. Here, we present the first evidence that Panx1 mutant mice are 
hypertensive, and confirm that they have normal heart mass and decreased vasodilatory 
responses to muscarinic receptor agonists. Importantly, the combined ablation of Cx40 and 
Panx1 led to decreased pre- and postnatal litter sizes, increased hypertension, and severe 
endothelial dysfunction. However, in other cases the phenotype of the Cx40 null mouse closely 
mirrored the Cx40-/-Panx1-/- mouse including the cardiac hypertrophy. This suggests that even 
though Panx1 and Cx40 large-pore channels may act via differential mechanisms, they have a 
co-regulatory role in controlling vascular response.  
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2.6 Supplementary Figures 
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Figure 2-9 (Supplementary Figure 2.1) Masson's Trichrome staining and assessment of 
ECM proteins in the hearts of mutant mice. 
Light micrographs of Masson’s Trichrome staining in the left (A) atria and (B) ventricle of 3 
month old mice revealed minimal fibrosis in all mutant mice. Western blotting revealed that the 
levels of collagen I and fibronectin were similar in mouse lysates of (C) atria and (D) whole 
hearts (N=3). Bar = 40 μm. 
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Figure 2-10 (Supplementary Figure 2.2) Mutant mice remain hypertensive under 
anesthesia. 
 (A) Tail-cuff hypertension testing revealed that anesthetized mutant mice have significantly 
higher systolic and diastolic blood pressure than wild-type mice, showing that anxiety effects did 
not cause previously reported hypertensive phenotypes (N=4). (B) Mean heart rate is variable 
among all four genotypes due to differential metabolism (N=4). p<0.001. 
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Chapter 3  
3 General Overview 
3.1 Discussion and Conclusions  
The gap junction protein Cx40 has long been categorized as an integral large-pore channel in 
cardiovascular physiology, participating in cardiac1, vascular, and renal system function2. More 
recently however, the single membrane channel forming protein, Panx1, has also emerged as a 
participant in the maintenance of cardiovascular system physiology. In fact, recent reports 
highlight the overlapping roles of Cx40 and Panx1 within the heart as the ablation of both of 
these genes leads to an increased susceptibility to atrial fibrillation3, 14. Within the vasculature 
Panx1 has also emerged as an important player and is implicated in α1-adrenoreceptor mediated 
vasoconstriction4, EDHF mediated vasodilation5, blood pressure regulation6, and renal function7. 
As well both Cx40 gap junction channels and Panx1 large pore channels are similarly localized, 
and abundant in the atria of the heart and within the arteries3, 8, 9, 10. Therefore due to the 
overlapping roles of these channels in cardiovascular function and their similar localization 
profiles we hypothesize that the global ablation of these two large-pore channels would lead to 
an increasingly severe cardiovascular phenotype.   
To this end, we engineered and phenotyped the first global knockout mouse model lacking both a 
connexin and a pannexin channel, specifically Cx40 and Panx1. Since both of these channel 
proteins have been reported to function in similar cellular signaling events and system 
physiology we predicted that the double knockout mouse would have a reduced ability to 
survive3, 11, 12, 13. This prediction was found to be accurate as the combined ablation of 
Panx1/Cx40 caused increased prenatal and neonatal mortality irrespective of fertility. Double 
knockout mice that survived 3 days post-birth were found to be viable and live normal lifespans. 
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Mutant mice lacking Cx40 and Panx1 were also similar in weight to single knockout and wild-
type mice up to a year of age indicating a normal metabolism.  Interestingly, there is conflicting 
evidence on Cx40-/- mouse survival and a previous report describes mild increases in 
pre/postnatal death in this mutant mouse line14. Comparably, although our findings were not 
statistically significant Cx40 null mice had 22% fewer births and 10% newborn pup deaths 
compared to wild-type mice. Moreover, although this phenotype presented as minor in the single 
Cx40 knockout mouse its severity was increased when Cx40 and Panx1 channels were co-
ablated as less than half of the Cx40-/-Panx1-/- litter survived to 3 days post birth.  These results 
may indicate a co-regulatory role for Cx40 and Panx1 in the development of the maturing 
embryo. They may also point towards the dynamic regulation of Panx1 channels along with 
Cx40 in embryonic heart development15 as previous authors hypothesized that single Cx40-/- 
pre/postnatal mortality was due to inadequate propagation within the cardiac conduction system 
and improper septation during the establishment of pulmonary circulation14. The developmental 
regulation of Panx1 throughout various organ systems is not a new idea and has been previously 
reported in skin16 in keeping with our findings that Panx1 may be developmentally regulated 
within the heart. Future studies to be performed should include a more in depth time point 
analysis of the in utero death of both Cx40-/-Panx1-/- and single Cx40 and Panx1 knockout strains 
in order to ascertain if embryo death is occurring before or after cardiac development. As well q-
PCR analysis of Panx1 transcript within the murine heart throughout embryonic development 
would allow us to conclude whether or not Panx1 is up or down regulated during embryo 
maturation and whether this dynamic regulation might be similar to that of the Cx40 large-pore 
channel.  
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Cardiac hypertrophy is often a secondary risk factor associated with hypertension induced 
pressure overload of the heart17. Within this organ, the left ventricle is the region primarily 
affected and may be characterized by reactivation of the fetal gene program and subsequent 
cardiomyocyte enlargement18.  Pathologic alterations associated with cardiac hypertrophy such as 
increased organ mass have been previously characterized in the Cx40 knockout mouse14. Here, 
we observed increased heart mass in young and adult Cx40-/- mice and confirmed that it was true 
cardiac hypertrophy by showing that left ventricular cardiomyocytes were enlarged. Somewhat 
surprisingly, the Cx40-/-Panx1-/- mouse possessed similar increases in cardiomyocyte area and the 
phenotype was not found to be increasingly severe. These findings are consistent with the 
conclusion that the ablation of Cx40 leads to the hypertrophic phenotype found in the Cx40-/-
Panx1-/- mouse irrespective of Panx1 ablation.  Additionally, increased left atrial cardiomyocyte 
area was observed in Cx40 and Cx40/Panx1 null mice. Intriguingly, unlike in the ventricle 
increases in left atrial cell size have been associated with cardiac conduction system 
abnormalities and the increased prevalence of atrial fibrillation19, which is curious since both 
Cx40-/- and Panx1-/- mice are increasingly susceptible to atrial arrhythmias3, 14.  
Cardiac hypertrophy is often accompanied by myocardial remodeling which may lead to 
arrhythmias, and subsequent heart failure20. Increased interstitial fibrosis, gap junction 
lateralization, and actin remodeling are all characteristic of this pathological process21. In our 
study this process had yet to be observed in the 3-month-old mice used here. To expand on these 
findings interstitial fibrosis due to excess ECM deposition was only minimally detected by 
Masson’s trichrome staining and there was no significant changes in collagen 1 or fibronectin in 
both the left atria and ventricle of all mice. This suggests that mutant mouse hearts were not 
particularly fibrotic. Similarly, the intercalated disc integrity and distribution of the gap junction 
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protein Cx43 and adherens protein N-cadherin was unaltered in mutant mice, and myofibril 
arrangement was not affected. Taken together these findings indicate that the cardiac 
hypertrophy found in single Cx40 and double Cx40/Panx1 knockout mice has not yet led to 
myocardial remodeling in these young adult aged mice. However because hypertrophy is often 
an adaptive physiological process in response to increased cardiac workload, and is plastic, we 
speculate that as Cx40-/- and Cx40-/-Panx1-/- mice age increases in fibrosis, and gap junction and 
cytoskeletal remodeling are likely to occur and therefore this phenomenon may be worthy of 
further investigation22.  
It has been documented that the ablation of one connexin may cause the down regulation of 
another family member23. The opposite has been found to be true for pannexins in the smooth 
muscle24. Recent reports have shown that when Panx1 is ablated Panx3 displays compensatory 
upregulation in smooth muscle cells24. Thus the assessment of levels and localization of the GJ 
protein Cx43 acted twofold, not only to confirm intercalated disc integrity, but also to ensure that 
this junctional protein had not been up or down regulated by the knockout of Cx40 and/or Panx1. 
Similarly, the profile of the GJ protein Cx40 was unchanged in wild-type and Panx1 null mice 
indicating that Cx40 and Panx1 do not act in a co-regulatory fashion.  An interesting follow up 
study would be to assess for Panx3 upregulation in the heart as this has yet to be done, and to 
characterize the aorta of the Cx40/Panx1 single knockouts and the double knockout mouse to 
ensure pannexin and connexins protein levels are unaltered.  
Due to previously published research describing the RAAS mediated hypertensive phenotype of 
the Cx40-/- mouse25 and the slightly hypotensive phenotype of smooth muscle specific Panx1-/- 
mice5, we postulated that Cx40/Panx1 co-ablation would have a normalizing effect on blood 
pressure. Therefore we performed tail-cuff blood pressure measurements on wild-type and 
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mutant mice and intriguingly not only was the Cx40-/- mouse found to be hypertensive but the 
Panx1-/- mouse possessed this phenotype as well.  Moreover the combined deletion of Cx40 and 
Panx1 created a double null mouse with a severely hypertensive phenotype. Although surprising 
these results were very interesting as they highlighted two key concepts; that Panx1 may play a 
role in blood pressure regulation irrespective of its function in smooth muscle cells, and that it 
may also play a protective role against the induction of cardiac hypertrophy.  
Hypertension is a multifactorial disease stemming from pathologies that provoke alterations in 
peripheral resistance and cardiac output26.  Because the Panx1 mutant mouse is a global knockout 
model it is hard to pinpoint the exact cause of its hypertensive phenotype however we can 
speculate here. Due to the widespread characterization of the small resistance arteries of a mouse 
in which Panx1 was selectively ablated from smooth muscle cells it is clear that the hypertensive 
phenotype found in the global Panx1-/- mouse is not due to increased arterial resistance but rather 
an effect of systemic knockout4, 5. Regulatory mechanisms that may be contributing to this 
phenomenon will be briefly delineated here, as they were previously discussed at some length in 
the introductory chapter.  There are two mechanisms linked to increased peripheral resistance 
that have been associated with Panx1 channel function. The first involves the stimulation of 
vasodilation during low oxygen conditions by the release of ATP from Panx1 channels located 
on erythrocytes27. The second mechanism involves Panx1 channels acting in feed-back 
regulation between the carotid body and brainstem for the regulation of arterial pressure28. 
Another factor that could contribute to increased arterial resistance in Panx1-/- mice is their 
blunted vasodilatory response to muscarinic agonists as shown previously29, and found in our 
current study. Moreover, Panx1 channels have been implicated in cardiac output changes due to 
their hypothesized role in pressure natriuresis and salt retention30. To summate Panx1 may play a 
93 
 
role in blood pressure regulation by modulating the aforementioned mechanisms either 
individually or together which is producing the hypertensive phenotype found in our global 
Panx1-/- mouse.  
The troubles in ascribing a specific mechanism to the increased blood pressure found in the 
Panx1-/- mouse emphasizes the drawbacks of the global ablation of a ubiquitous protein involved 
in many physiological responses. With new Cre-lox technology the selective ablation of Panx1 in 
relevant organs, such as the kidney, could help predict causality. To add, the Panx1 gene has yet 
to be selectively deleted from the kidney so this mouse model would not only be relevant to the 
study of hypertension in these animals, but also to help define the roles of Panx1 in renal 
physiology. An additional follow up study that could help shed some light on this phenomenon, 
without the involved process of creating a new transgenic mouse line would be to assess the 
levels of renin, angiotensin, and aldosterone in the plasma of the Panx1-/- mice. Kidneys could 
also be harvested, sectioned, stained and assessed for general structural characteristic such as 
nephron number, atrophy, and cell death.  
Another important consideration when addressing the results of the tail-cuff hypertension testing 
is the sophistication and sensitivity of the technique itself. Tail cuff testing is an indirect blood 
pressure monitoring technique that uses various sensing modalities to detect changes in blood 
flow during cuff occlusion31. Advantages in using this approach include: the non-invasiveness of 
the technique dissuading from costly and time-consuming surgical methods, the ability to 
perform repeat measures over a longer time-frame, the animals remain conscious, and the ability 
to perform measurements on large cohorts of animals32. It is said to be an optimal technique 
when trying to detect large changes in systolic/diastolic pressures33. Two main disadvantages of 
tail cuff blood pressure monitoring are the small sampling period which is measured and that it 
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may act as an acute system stressor34, 35. Many researchers have postulated that since tail cuff 
only measures a minute period of the circadian cycle and does not reflect changes in both day 
and night cycles it is not an accurate measure to obtain an average blood pressure34. As well, due 
to the fact that rodents are nocturnal, obtaining blood pressure values when they are most active 
may be of vital importance to the study34. A second caveat to the tail cuff blood-pressure 
monitoring system is that restraint induces acute stress in rodents, which may affect short-term 
pressure measurements35. In fact several studies have found that restraint stress causes acutely 
elevated blood-pressure and increased stress hormone production35, 36. In our study to circumvent 
this issue mice were given a 2-week acclimatization period in which they were conditioned to the 
CODA system. As well, tail-cuff blood pressure measurements were performed on anesthetized 
mice to rule-out acute stress and anxiety affects and all three mutant mouse lines remained 
hypertensive compared to wild-type. Furthermore, in order to validate our system for measuring 
blood pressure, a previous study was performed in which tail cuff blood-pressure measurements 
taken on the CODA system were compared to radiotelemetry measurements and found to be 
nearly identical37.  In the future radiotelemetric studies could be performed on our mutant mice to 
assess their blood pressure throughout the full length of the circadian cycle.  
Interestingly, although the Panx1 null mice presented with hypertension they did not show 
concomitant cardiac hypertrophy as was observed in Cx40-/- and Cx40-/-Panx1-/- mice. This 
finding although intriguing, is not entirely unique. In the human population a multitude of studies 
show that only half of the variability in left ventricular mass can be attributed to increased blood 
pressure (as reviewed by Katholi)38.  To try and elucidate alternative causes for the induction of 
cardiac hypertrophy genetic factors, the NO/cGMP pathway and neurohormones have been 
investigated and found to play a role in hypertrophic growth39, 40. Therefore our findings in the 
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Panx1-/- mouse model show that this large-pore channel may play a previously unknown role in 
the development of cardiac hypertrophy.  
Within blood vessels the endothelium is highly involved in the regulation of vascular tone by 
modulating contractile responses and mediating the release of vasodilators41. This balance is 
often disrupted secondary to hypertension leading to endothelial dysfunction and deficits in 
endothelium-mediated vasodilation41. As previously noted in the introductory chapter both Cx40 
and Panx1 large-pore channels influence vascular tone in elastic arteries by modulating 
vasodilatory responses, and Cx40-/- and Panx1-/- mice have been shown to possess blunted 
vasodilatory responses to muscarinic receptor agonists 42, 43, 44. As well, since both of these 
channel proteins are localized to endothelial cells in larger arteries, we hypothesized that the 
combined ablation of Cx40 and Panx1 would lead to a severe loss of endothelial function45, 46. 
Consistent with this notion our experimental results demonstrate that the concomitant ablation of 
Cx40 and Panx1 in our double knockout mouse model had a cumulative effect on vasodilatory 
responses and creating an increasingly blunted response. The minimal vasodilatory response in 
the aorta of double null mice to the muscarinic agonist MCh was not mimicked when an 
endothelium independent vasodilator was applied, indicating that these mice possess severe 
endothelial dysfunction. Due to its severity we speculate that the endothelial damage seen in the 
Cx40-/-Panx1-/- mouse is due to a combination of the down regulation of vasodilatory pathways 
regulated by Cx40 and Panx1, namely NO and EDHF mediated vasodilation, and hypertension 
damage29, 44.  
In conclusion this research contributed several distinct and unique findings to the gap junction 
and pannexin fields. We engineered the first ever connexin/pannexin global knockout mouse 
from Cx40 and Panx1 single knockout animals and characterized this novel model for overt 
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phenotypes. This characterization revealed Cx40-/-Panx1-/- mice that did survive past day 3, had 
normal weights, and were fertile. Single Cx40-/- mice exhibited previous reported phenotypes 
including cardiac hypertrophy, hypertension, and blunted vasodilatory responses. Interestingly, 
within the Cx40 null heart cardiac hypertrophy had not yet led to myocardial remodeling. 
Similarly, it was confirmed that Panx1 null mice possess normal heart size and decreased 
vasodilatory responses to muscarinic agonists. Remarkably global Panxl knockout mice were 
discovered to be hypertensive, a finding which has been previously unreported in the literature.  
As well, the combined ablation of Cx40 and Panx1 was found to lead to increased embryonic 
and neonatal mortality, severe hypertension, and augmented endothelial dysfunction.  Therefore 
the results found in this thesis suggest that Panx1 and Cx40 large pore channels have co-
regulatory roles in certain physiological processes including embryonic and neonate survival, 
hypertension, and vascular responses.  
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